EASL Lancet commission – Autoimmune Liver Disease in Europe – Patient Survey
Health care professionals and patient groups are working together to find out more about the experience of patients with autoimmune liver conditions across Europe. The results of this survey will be used…
Survey on Paediatric Liver Care across Europe for the EASL Lancet Commission
Dear Colleague EASL has been commissioned by the UK journal, The Lancet to work together to create an EASL Lancet Commission on Liver Disease in Europe. I am chairing the Paediatric and…
EASL Governing Board appoints Ben Hainsworth as incoming Managing Director
Starting September 2019 Hainsworth will serve as the interface between the EASL Governing Board and the organisation`s Geneva and Brussels operations, ensuring high quality and effective implementation of the Governing Board`s policies…
Journal of Hepatology achieves best ranked publication on liver disease
GENEVA, Switzerland Last week, ClarivateTM Analytics released the 2019 update of its Journal Citation Reports©, including the much anticipated 2018 impact factor. EASL’s flagship monthly journal, the Journal of Hepatology achieved unprecedented…
Spirits industry afraid of their own ingredients?
The public health community is greatly disappointed about the SpiritsEurope approach to label their products. In our view, the European spirits industry refrains from informing consumers at the point of sale in…
Future of Continuing Medical Education
Scientific progress is constantly reshaping clinical practice. Therefore, it is crucial that medical professionals continuously adapt to novel and better approaches for patient management. A hugely important part of a doctor’s development…
Immediate EU action on non-communicable diseases could help save almost 2 million lives by 2025
The European Chronic Disease Alliance (ECDA), the European Public Health Alliance (EPHA) and the NCD Alliance publish a new joint paper “Towards an EU-Strategic Framework for the prevention of Non-communicable Diseases” concluding…
